Abstract Prognosis in Acute Drug-induced Liver Injury Liver Injury Pattern Presentation and DILI Outcome Chronic Liver Disease as a DILI Outcome References Chronic Liver Disease as a DILI Outcome ...
Drug-induced liver injury (DILI) is common because it can be caused by different pharmacological agents from nearly all classes of medications, including hepatotoxic drugs, anesthetics, anticancer ...
A new study says millions across the world take botanical supplements that could potentially cause permanent liver damage or ...
A study in JAMA Network Open reveals a rise in drug-induced liver injuries associated with herbal supplements like green tea ...
Drug-induced liver injury including cholestasis is another form of acquired liver disease, accounting for approximately 2 to 5% of hospitalizations for jaundice, 10% of cases of hepatitis in all ...
It is generally accepted that IL6-mediated STAT3 signaling in hepatocytes, mediated via glycoprotein 130 (gp130; IL6ST), is beneficial and that the synthetic IL6:IL6ST fusion protein (HyperIL6) ...
The FDA has updated the prescribing information for Veozah (fezolinetant) to include a warning regarding the risk of serious liver injury.
Data from the HERCULES trial presented at the ECTRIMS conference in Copenhagen, Denmark, today showed that tolebrutinib was ...
Recent draft guidance highlights the challenges that industry and regulators face to predict rare drug-induced liver injury. At the end of August 2008, the consultation period ended for comments ...
CHICAGO -- The non-hormonal drug elinzanetant reduced the frequency of moderate-to-severe hot flashes in postmenopausal women ...
"The Drug Induced Liver Injury Network (DILIN), a multicenter U.S. observational program that collects and analyzes data from patients with hepatotoxic effects attributed to various drugs and HDS ...
“Applying multi-omics to cancer is relatively easy,” says biologist Jean-François Deleuze, coordinator of The Laboratory of Excellence in Medical Genomics (GENMED) and director of the ...